Loading Events

« All Events

  • This event has passed.

Safe Use of Chemotherapy in Practice

7 March - 27 March


Safe Use of Chemotherapy in Practice

Knowledge of the indications and administration techniques of chemotherapy agents used in the treatment of cancer in pets is of paramount importance to achieve the best outcome in terms of survival and quality of life by avoiding ineffective treatments and preventing significant adverse effects. This Safe Use of Chemotherapy course aims to be a practical guide to the safe dosing, preparation and administration in general practice of the most commonly used chemotherapy drugs for the treatment of cancer in small animals and their monitoring. The course will concentrate on the most commonly used chemotherapy protocols for the treatment of lymphoma and solid tumours such as carcinomas, sarcomas and mast cell tumours, while receiving an update on new medications and techniques available for your patients such as electrochemotherapy, metronomic chemotherapy, tyrosine kinase inhibitors and immunotherapy!

Safe Use of Chemotherapy Modules

Module 1: Chemotherapy – what is it and when to use it*
*contains main indications for the use of chemotherapy in pets

Module 2: Chemotherapy Drugs & Protocols – Solid tumours

Module 3: Chemotherapy Drugs & Protocols – Lymphoma

Module 4: Monitoring the Veterinary Chemotherapy Patient

Module 5: ABC of Chemotherapy Preparation and Administration

Module 6: Chemotherapy Health and Safety in Your Practice

Module 7: Gastrointestinal toxicity, Neutropenia and Extravasation injury

Module 8: Bladder toxicity, Acute reactions and Toxicity from Tyrosine Kinase inhibitors

All our Tutored Online CPD Courses are written and taught by an expert in the relevant field. The tutor for this course is:


Dr Chiara Penzo DVM PhD Dip.ECVIM (Oncology) MRCVS. European and RCVS Recognised Veterinary Specialist in Oncology

How useful was this CPD?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Be the first to comment

Leave a Reply